Detection of Pulmonary Involvement in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss, EGPA) with 18F-fluorodeoxyglucose Positron Emission Tomography  by Horiguchi, Yoriko et al.
Allergology International Vol 63, No1, 2014 www.jsaweb.jp 121
Fig.　1　An FDG PET image obtained 1 hour after adminis-
tration of FDG (early image) shows multiple regions of FDG 
uptake with lymphadenopathy in mediastinal and hilar lymph 
nodes (arrows).
Dear Editor
Detection of Pulmonary Involvement in
Eosinophilic Granulomatosis with
Polyangiitis (Churg-Strauss, EGPA)
with 18F-fluorodeoxyglucose Positron
Emission Tomography
Eosinophilic granulomatosis with polyangiitis (Churg-
Strauss, EGPA) is a systemic necrotizing vasculitis in
the small vessels associated with eosinophilic infiltra-
tion and granulomatous inflammation in various or-
gans. 1 Eosinophilic inflammation and small-vessel
vasculitis induce various disorders in organs, includ-
ing the lung, heart, intestine, kidney, skin, central
nervous system, and peripheral nerves.2 The clinical
manifestations of EGPA are bronchial asthma, eosino-
philia, pulmonary infiltrates, parasinusitis, multiple
mononeuritis, and extravascular eosinophils.3
Inflammation in various diseases has been as-
sessed with 18F-fluorodeoxyglucose (FDG) positron
emission tomography (PET), but there have been few
reports on the use of FDG PET in EGPA.4,5 We de-
scribe a patient with EGPA who underwent FDG
PETcomputed tomography (CT) before treatment
and is now in complete remission.
A 66-year-old man had been seen at a hospital for
refractory chronic eosinophilic pneumonia since he
was 63 years old. He had a history of asthma of Step 4
severity according to the 2006 Global Initiative for
Asthma guidelines6; recurrent eosinophilic otitis me-
dia; sinusitis; and eosinophilia, with eosinophils ac-
counting for 20%―30% of white blood cells. He was
treated with a high dose of an inhaled corticosteroid,
a leukotriene receptor antagonist, and a histamine
H 1-receptor antagonist ; nevertheless, he suffered
from wheezing with chronic cough. In July 2010,
when he was 66 years old, he developed diarrhea,
purpura in the forearms, sensory disturbance with
mild weakness in his lower extremities, and left tibial
paralysis. He underwent FDG PETCT as part of a
medical examination for cancer in Musashimurayama
Hospital, Tokyo, Japan in July 2010. With the patient
in the fasting state, images were taken of the body
from the head to the thighs at 1 hour (early images)
and 2 hours (delayed images) after intravenous injec-
tion of 212 MBq of FDG. FDG PETCT showed hilar
and mediastinal lymph node swelling with increased
FDG uptake (Fig. 1); the maximal standardized up-
take value (SUV) was 3.44 in the early image (Fig. 2
A) and 5.77 in the delayed image. CT revealed a re-
ticular shadow, ground-glass opacity, and bronchial
wall thickening associated with atelectasis in the bi-
lateral lower lobes of the lung. FDG accumulated in a
lesion in the left lower lobe of the lung with a maxi-
mal SUV of 2.28 in the early image (Fig. 2B) and 3.56
in the delayed image. No abnormally high FDG accu-
mulation was detected in other organs.
In August 2010, peripheral blood analysis revealed
increases in total white blood cell (WBC ) count
( 11,380mm3 ; normal, 3500 to 8500mm 3 ) and
eosinophil count (5804mm3, 51% of total WBC count;
normal, 0% to 6%), and C-reactive protein (CRP) was
elevated (1.11 mgdL ; normal, 0 to 0.4 mgdL) .
Myeloperoxidase-specific antineutrophil cytoplasmic
antibodies were not detected. The patient was sus-
pected to have EGPA and was admitted to National
Hospital Organization Sagamihara National Hospital,
Kanagawa, Japan in September 2010. Bronchoalveo-
lar lavage fluid contained numerous eosinophils,
which comprised 75.5% of the total cell count (total
cell count, 8.2 × 104mL). Histologic examination of
the bronchial tissue revealed prominent eosinophil
infiltration and edema of the tunica propria under the
bronchial epithelium. Lung biopsy demonstrated a
thickening of the alveolar septum, which was infil-
trated by eosinophils. Biopsy of the stomach and co-
lon did not show eosinophilic infiltration. No granulo-
matous lesion or necrotizing angiitis was detected in
specimens of the lung, stomach, and colon. He expe-
rienced no cardiac symptoms, such as chest pain, pal-
pitation, and dyspnea on effort. Electrocardiography
and echocardiography revealed no abnormal find-
ings. The patient was diagnosed with EGPA accord-
ing to the diagnostic criteria for allergic granulomato-
sus angiitis proposed by the research committee of
intractable vasculitis in the Japanese Ministry of
Health, Labor, and Welfare.7 The EGPA of the patient
in this report was complicated by advanced eosino-
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Fig.　2　Early FDG PET/CT images of the chest show in-
creased FDG uptake in the mediastinal and hilar lymph nodes 
(A) and in an infi ltration in the left lower lobe of the lung (B).
A
B
philic pneumonia with lymph node adenopathy, multi-
ple mononeuritis, paranasal sinusitis, otitis media,
and purpura.
The patient was treated with intravenous methyl-
prednisolone (1 gday for three consecutive days) fol-
lowed by oral prednisolone (60 mgday for the first
month and then a gradually decreasing dose), intra-
venous cyclophosphamide (700 mg given three times
at intervals of three weeks), and intravenous immu-
noglobulin (25 gday for five consecutive days). His
symptoms improved after the treatment. Blood analy-
sis revealed that total WBC count, eosinophil count,
and CRP had decreased to the normal range at ten
weeks after treatment was started ( WBC count,
8240mm3; eosinophil count, 40mm3, 0.5% of total
WBC count; CRP, 0.25 mgdL). CT was performed
again in October 2010 and demonstrated improve-
ment of the lung infiltration and disappearance of me-
diastinal and hilar lymph node swelling. In April 2013,
the patient was in complete remission and underwent
FDG PETCT at Musashimurayama Hospital. The
CT images and FDG uptake were normal.
In this patient, FDG PETCT detected severe pul-
monary involvement associated with EGPA. FDG
PET showed advanced eosinophilic inflammation af-
fecting the lung and mediastinal lymph nodes in a pa-
tient with EGPA before treatment. However, the abil-
ity of FDG PET to detect pulmonary inflammation
may be lower than that of CT because FDG did not
show abnormal uptake in the right lower lobe, in
which CT found pulmonary inflammation. FDG PET
did not reveal otitis media and sinusitis, perhaps be-
cause the inflammation of the middle ear and parana-
sal sinus were mild. FDG appropriately did not accu-
mulate in the stomach and colon, in which neither
eosinophilic nor necrotizing inflammation was de-
tected in histological examination. In this case, FDG
PET did not exceed conventional examinations in de-
tecting inflammation in EGPA, although FDG PET
has reportedly detected active myocardial inflamma-
tion in patients with EGPA both before treatment and
after remission.4,5 FDG PET has also been used to
evaluate the degree and extent of inflammation in
large-vessel vasculitis and Wegener granulomato-
sis.8,9 Prospective clinical trials are needed to confirm
the utility of FDG PET in patients with EGPA.
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